Cardinal Partners


	Alnylam Advances RNAi Therapeutics Pipeline and Files Company's First Systemic Delivery IND
	December 23, 2008
	Alnylam Publishes Pre-Clinical Research on Direct CNS Delivery of RNAi Therapeutics
	December 19, 2008
	athenahealth Assumes Top National Ranking in 2008 KLAS Practice Management Category for Small Physician Practices
	December 17, 2008
	Momenta Pharmaceuticals to Raise $24.1 Million Through Registered Direct Offering
	December 12, 2008
	Alnylam Pharmaceuticals and Roche Collaboration Selected as Best Partnership Alliance by Scrip
	December 11, 2008
	Alnylam Provides Update on Kreutzer-Limmer Patent Family
	December 09, 2008
	Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
	December 08, 2008
	Alnylam Strengthens Intellectual Property Estate through Acquisition of Nucleonics Patent Assets
	December 08, 2008
	Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum
	December 04, 2008
	Cubist Pharmaceuticals Names Santosh J. Vetticaden as Senior Vice President, Clinical Development and Chief Medical Officer
	December 02, 2008
	Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever
	November 30, 2008
	Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
	November 20, 2008
	athenahealth to Host First Annual Investor Summit
	November 19, 2008
	IMM, Cenix, and Alnylam Discover New Targets in Malaria Infection with RNAi Technology
	November 11, 2008
	USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities
	November 11, 2008
	The Boston Globe names Cubist to Globe 100's Top Places to Work '08
	November 10, 2008
	Regulus Therapeutics and Collaborators Discover Role of a microRNA in Tumor Angiogenesis
	November 06, 2008
	athenahealth, Inc. Reports Third Quarter 2008 Results
	November 06, 2008
	Alnylam Pharmaceuticals Reports Third Quarter 2008 Financial Results
	November 05, 2008
	Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Key Gene Implicated in Parkinson's Disease
	November 04, 2008
	Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms
	November 03, 2008
	Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2008
	November 03, 2008
	Rib-X C.E.O. Susan Froshauer, Ph.D., Honored by The Connecticut Women's Hall of Fame
	October 31, 2008
	Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC / IDSA Joint Meeting
	October 26, 2008
	CUBICIN(R) Outcomes Registry and Experience (CORE(R)) Marks Milestone
	October 21, 2008
	Medical Practices Maximize Incentive Payments Using athenahealth's National Physician Network for the Physician Quality Reporting Initiative
	October 20, 2008
	Sirtris CEO Christoph Westphal Selected by Biotech CEOs as Outstanding Individual
	October 16, 2008
	Cubist Pharmaceuticals Q3 2008 Revenues up 41%; Net Income up 39%: Total Revenues $112.4 Million; CUBICIN(R) Net Product Revenues $110.6 Million
	October 16, 2008
	Alnylam Scientists Present Data from Multiple Programs at the 4th Annual Meeting of the Oligonucleotide Therapeutics Society
	October 15, 2008
	athenahealth Chief Operating Officer and Executive Vice President Retires Due to Health Reasons
	October 08, 2008
	Alnylam Earns $20 Million Payment from Takeda
	October 07, 2008
	Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
	October 01, 2008
	Sirtris’ Review of Sirtuin Therapeutics for Diseases of Aging in the Journal Nature Reviews Drug Discovery
	October 01, 2008
	Cubist Pharmaceuticals Opens New Research Facility at Lexington Headquarters
	September 29, 2008
	OrthoArkansas Joins Growing List of Leading Orthopedic Groups Leveraging athenahealth's National Physician Network and On-Demand Services
	September 16, 2008
	Sirtris Completes Exclusive License to Harvard's SIRT3-Based Intellectual Property
	September 16, 2008
	Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Pharmaceuticals Discover New Pathway for Malaria Infection
	September 11, 2008
	athenahealth Completes Acquisition of MedicalMessaging.net Assets
	September 08, 2008
	Cubist Pharmaceuticals Provides Update on Advancing Product Pipeline
	September 08, 2008
	Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
	September 08, 2008
	Suncoast Medical Clinic Selects athenahealth's On-Demand Practice Management and Billing Service
	September 04, 2008
	Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
	September 03, 2008
	Cubist Pharmaceuticals to Host Investor Event: Act 2 - Raising the Curtain on Cubist's Pipeline
	September 02, 2008
	Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
	September 02, 2008
	Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors
	August 19, 2008
	Presbyterian Anesthesia Associates Goes Live on athenahealth's Software-Enabled Service, athenaCollector(SM)
	August 15, 2008
	Alnylam and Collaborators Publish New Pre-Clinical Research on RNAi-Mediated Silencing of PCSK9, a Genetically Validated Regulator of LDL Metabolism
	August 12, 2008
	Alnylam Forms Collaboration with Max Planck Institute to Investigate Biological Mechanisms for Cellular Uptake of RNAi Therapeutics
	August 11, 2008
	Alnylam Awarded Continued Funding Under U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats
	August 06, 2008
	athenahealth to Acquire MedicalMessaging.net Assets, Gaining New Patient Communications Service Capabilities
	August 04, 2008
	Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression
	August 04, 2008
	Rib-X Pharmaceuticals, Inc. Appoints Dr. George Milne as Executive Chairman of the Board of Directors
	July 31, 2008
	RediClinic to Leverage athenahealth's EMR and Practice Management Services for its National Retail Clinic Network
	July 30, 2008
	Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection
	July 29, 2008
	Momenta Pharmaceuticals Announces Results from M118 Drug-Drug Interaction Study with Aspirin and Clopidogrel
	July 28, 2008
	Intellectual Property License to Calando for Development and Commercialization of RNAi Therapeutics
	July 21, 2008
	Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
	July 16, 2008
	RIB-X PHARMACEUTICALS INITIATES PHASE 2 TRIAL FOR RX-3341 IN COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS
	July 15, 2008
	Long-Term Study of Middle-Aged Mice Shows Resveratrol Improves Health and Mimics Some Benefits of Dietary Restriction
	July 03, 2008
	Cubist to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
	July 02, 2008
	Cubist to Announce 2Q08 Financial Results on July 17, 2008
	July 01, 2008
	Cubist Testifies on Need to Encourage Antibiotic Research and Development
	June 24, 2008
	Cubist Appoints Mark H.N. Corrigan, M.D., to its Board of Directors
	June 24, 2008
	athenahealth Appoints New General Counsel
	June 19, 2008
	Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
	June 19, 2008
	Cubist Appoints Nancy J. Hutson, Ph.D., to its Board of Directors
	June 16, 2008
	Wayne State University Physician Group Selects athenahealth's Centrally-Hosted Practice Management Services
	June 05, 2008
	GLAXOSMITHKLINE SUCCESSFULLY COMPLETES TENDER OFFER FOR SHARES OF SIRTRIS PHARMACEUTICALS
	June 02, 2008
	Aetna Ranks First in 2008 PayerView(SM) Ranking; Pays Medical Providers the Fastest Among National Commercial Insurers
	May 29, 2008
	athenahealth to Release 2008 PayerView(SM) Rankings
	May 28, 2008
	Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
	May 27, 2008
	Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics
	May 13, 2008
	Alnylam Pharmaceuticals Reports First Quarter 2008 Financial Results
	May 08, 2008
	Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008
	May 07, 2008
	Thomson Reuters and Lance Armstrong Foundation Provide Online Cancer Information
	May 06, 2008
	athenahealth, Inc. Reports First-Quarter 2008 Results
	May 06, 2008
	Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
	May 06, 2008
	Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases
	May 06, 2008
	Connecticut State Medical Society Joins with athenahealth to Offer On-Demand Practice Management Services to Physicians Statewide
	May 02, 2008
	GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
	May 02, 2008
	Sirtris Pharmaceuticals Reports First Quarter 2008 Financial Results
	May 01, 2008
	Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA
	April 29, 2008
	GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
	April 22, 2008
	Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection
	April 09, 2008
	athenahealth, Inc. Reports Fourth-Quarter and Full-Year 2007 Results
	March 05, 2008
	Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis
	March 04, 2008
	Thomson Healthcare Cancer Profiler used in study
	March 03, 2008
	athenahealth Awarded Community Health Systems Contract
	February 27, 2008
	Sirtris Pharmaceuticals Reports Fourth Quarter and 2007 Financial Results; Significant Progress Achieved
	February 25, 2008
	Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2007
	February 14, 2008
	Leonard P. Guarente, a Founder of the Sirtuin Field, Signs Exclusive Consulting Agreement with Sirtris Pharmaceuticals
	February 05, 2008
	Thomson Healthcare online treatment tools mark milestone
	February 02, 2008
	athenahealth's National Physician Network Live With New Centers for Medicare and Medicaid Services Pay-For-Performance Measures
	January 29, 2008
	Alnylam Announces Grant of New Patent Covering RNAi Therapeutics in the United Kingdom
	January 28, 2008
	Cubist Pharmaceuticals Reports GAAP Diluted Net Income of $0.16 Per Share in Fourth Quarter 2007 and GAAP Diluted Net Income of $0.85 Per Share for Full Year 2007
	January 23, 2008
	AccentCare Newport Beach Ranked Among the Top 25 Percent of Home Health Providers in the Country for 2007
	January 23, 2008
	Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
	January 04, 2008

Current Portfolio News

Archive Portfolio News